# Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy

> **NCT07166302** · — · RECRUITING · sponsor: **Masaryk University** · enrollment: 70 (estimated)

## Conditions studied

- Direct Acting Anticoagulant Adverse Reaction
- Needle Injury
- EMG
- Peripheral Neuropathies
- Mononeuropathies
- Polyneuropathies
- Neuromuscular Diseases (NMD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07166302
- **Lead sponsor:** Masaryk University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07166302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07166302, "Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07166302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*